Chagas' disease: an update on immune mechanisms and therapeutic strategies
Data
2010-06-01
Autores
Boscardin, Silvia Beatriz
Troccoli Torrecilhas, Ana Claudia
Manarin, Romina
Revelli, Silvia
Gonzalez Rey, Elena
Tonelli, Renata Rosito [UNIFESP]
Silber, Ariel Mariano
Orientadores
Tipo
Resenha
Título da Revista
ISSN da Revista
Título de Volume
Resumo
The final decade of the 20th century was marked by an alarming resurgence in infectious diseases caused by tropical parasites belonging to the kinetoplastid protozoan order. Among the pathogenic trypanosomatids, some species are of particular interest due to their medical importance. These species include the agent responsible for Chagas' disease, Trypanosoma cruzi. Approximately 8 to 10 million people are infected in the Americas, and approximately 40 million are at risk. in the present review, we discuss in detail the immune mechanisms elicited during infection by T. cruzi and the effects of chemotherapy in controlling parasite proliferation and on the host immune system.
Descrição
Citação
Journal of Cellular and Molecular Medicine. Malden: Wiley-Blackwell, v. 14, n. 6B, p. 1373-1384, 2010.